4.6 Article

The Role of ROS as a Double-Edged Sword in (In)Fertility: The Impact of Cancer Treatment

期刊

CANCERS
卷 14, 期 6, 页码 -

出版社

MDPI
DOI: 10.3390/cancers14061585

关键词

reactive oxygen species (ROS); oxidative stress; chemotherapy; targeted agents; (in)fertility

类别

资金

  1. Unit for Multidisciplinary Research in Biomedicine (UMIB) - Foundation for Science and Technology (FCT) Portugal [UIDB/00215/2020, UIDP/00215/2020]
  2. ITR-Laboratory for Integrative and Translational Research in Population Health [LA/P/0064/2020]
  3. Portuguese Government
  4. European Union [DL57/2016/CP1327/CT0006]

向作者/读者索取更多资源

Tumor cells exhibit high resistance to oxidative stress, but excessive oxidative stress beyond a certain threshold can lead to cell death. Inducing imbalance in redox homeostasis can be a strategy in anticancer therapies, but the mechanisms behind the loss of fertility are still unknown. With the increasing life expectancy of cancer patients, it is important to consider the potential adverse effects of anticancer treatments on reproductive capacity.
Simple Summary Tumor cells are highly resistant to oxidative stress, but beyond a certain threshold, it may lead to apoptosis/necrosis. Thus, induced loss of redox balance can be a strategy used in anticancer therapies. However, the effectiveness of drugs contrasts with unknown mechanisms involved in the loss of fertility. Considering that cancer patients' life expectancy is increasing, it raises concerns about the unknown adverse effects. Therefore, new strategies should be pursued alongside explaining to the patients their options regarding the reproduction side effects. Tumor cells are highly resistant to oxidative stress resulting from the imbalance between high reactive oxygen species (ROS) production and insufficient antioxidant defenses. However, when intracellular levels of ROS rise beyond a certain threshold, largely above cancer cells' capacity to reduce it, they may ultimately lead to apoptosis or necrosis. This is, in fact, one of the molecular mechanisms of anticancer drugs, as most chemotherapeutic treatments alter redox homeostasis by further elevation of intracellular ROS levels or inhibition of antioxidant pathways. In traditional chemotherapy, it is widely accepted that most therapeutic effects are due to ROS-mediated cell damage, but in targeted therapies, ROS-mediated effects are mostly unknown and data are still emerging. The increasing effectiveness of anticancer treatments has raised new challenges, especially in the field of reproduction. With cancer patients' life expectancy increasing, many aiming to become parents will be confronted with the adverse effects of treatments. Consequently, concerns about the impact of anticancer therapies on reproductive capacity are of particular interest. In this review, we begin with a short introduction on anticancer therapies, then address ROS physiological/pathophysiological roles in both male and female reproductive systems, and finish with ROS-mediated adverse effects of anticancer treatments in reproduction.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据